Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Pulmonary Arterial Remodeling

rosiglitazone has been researched along with Pulmonary Arterial Remodeling in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahsan, F; McMurtry, IF; Nozik-Grayck, E; Rashid, J; Stenmark, KR1
Alvarez, L; Corcionivoschi, N; Friedmacher, F; Gosemann, JH; Hofmann, A; Kuebler, JF; Lacher, M; Puri, P; Rittinghausen, S; Suttkus, A; Zimmer, J1
Akiyama, TE; Berger, JP; Chang, CH; Gonzalez, FJ; Lightbody, ED; Liu, H; McNamara, LA; Nicol, CJB; Rubino, RE; Sharma, N; Shi, JY; Skelhorne-Gross, GE; Woods, JW; Zycband, EI1
Bijli, KM; Carthan, KA; Green, DE; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Park, KK; Searles, CD; Sutliff, RL; Yeligar, SM1

Other Studies

4 other study(ies) available for rosiglitazone and Pulmonary Arterial Remodeling

ArticleYear
Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.
    American journal of physiology. Lung cellular and molecular physiology, 2019, 01-01, Volume: 316, Issue:1

    Topics: Administration, Inhalation; Animals; Drug Therapy, Combination; Heart Function Tests; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sildenafil Citrate; Vascular Remodeling

2019
Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia.
    PloS one, 2018, Volume: 13, Issue:11

    Topics: Animals; Chemokine CCL2; Disease Models, Animal; Female; Gene Expression; Hernias, Diaphragmatic, Congenital; Immunohistochemistry; Lung; Macrophages; Monocytes; Phenyl Ethers; Pregnancy; Prenatal Care; Rats; RNA, Messenger; Rosiglitazone; Vascular Remodeling

2018
Endothelial Cell-Targeted Deletion of PPAR
    The Journal of pharmacology and experimental therapeutics, 2019, Volume: 368, Issue:3

    Topics: Adipose Tissue; Animals; Endothelial Cells; Gene Deletion; Hypoglycemic Agents; Male; Mice; Mice, Transgenic; Plasma Volume; PPAR gamma; Rosiglitazone; Vascular Remodeling

2019
Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
    American journal of respiratory cell and molecular biology, 2016, Volume: 54, Issue:1

    Topics: 3' Untranslated Regions; Animals; Binding Sites; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelin-1; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; PPAR gamma; Pulmonary Artery; Pyrroles; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transfection; Vascular Remodeling

2016